GLUT4-IN-2(Cat No.:I043823)is a small molecule inhibitor designed to modulate the activity of GLUT4 (glucose transporter type 4), a protein responsible for insulin-stimulated glucose uptake into cells, particularly in muscle and adipose tissue. By inhibiting GLUT4, this compound may impact glucose homeostasis, providing potential therapeutic benefits in conditions like insulin resistance, obesity, and type 2 diabetes. GLUT4-IN-2 could be useful in studying the role of GLUT4 in cellular metabolism and in developing treatments that regulate glucose uptake. Research is ongoing to evaluate its efficacy, safety, and potential applications in metabolic disorders.